SETIAWAN, S. I., and P. ASCOBAT. “ADVERSE REACTIONS TO FIRST-LINE ANTI-TUBERCULOSIS DRUGS AS A RISK FACTOR OF PULMONARY TUBERCULOSIS TREATMENT DEFAULT IN JAKARTA, INDONESIA”. International Journal of Applied Pharmaceutics, vol. 11, no. 6, Dec. 2019, pp. 80-83, doi:10.22159/ijap.2019.v11s6.33551.